These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 106466)

  • 21. [Nephrotic syndrome due to gold salts (apropos of 4 cases)].
    Renier JC; Boasson M; Bernat M; Fressinaud P
    Sem Hop; 1973 Mar; 49(12):881-9. PubMed ID: 4352984
    [No Abstract]   [Full Text] [Related]  

  • 22. Nephrotoxic effect of parenteral and intraarticular gold. Ultrastructure and electron microprobe examination of clinical and experimental material.
    Yarom R; Stein H; Peters PD; Slavin S; Hall TA
    Arch Pathol; 1975 Jan; 99(1):36-42. PubMed ID: 803366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Parenteral gold therapy (Tauredon) in chronic polyarthritis].
    Tausch G; Gaismayer K
    Wien Klin Wochenschr Suppl; 1984; 156():19-21. PubMed ID: 6442051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Studies of protein clearance in patients treated with and without gold preparations in rheumatoid arthritis].
    Gräfenstein K
    Z Gesamte Inn Med; 1987 Jan; 42(2):56-8. PubMed ID: 3107230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Granulomatous glomerulonephritis in a patient with rheumatoid arthritis treated with gold salts.
    Skrifvars B; Törnroth T; Falck HM
    Scand J Rheumatol; 1979; 8(4):234-40. PubMed ID: 118527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Auranofin and sodium aurothiomalate in the treatment of rheumatoid arthritis. A double-blind, comparative multicenter study.
    Schattenkirchner M; Kaik B; Muller-Fassbender H; Rau R; Zeidler H
    J Rheumatol Suppl; 1982; 8():184-9. PubMed ID: 6813483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of rheumatoid arthritis with gold salts].
    Aranguena L; Hinojosa W; Chincaro C; Portugal J; Barrenechea O
    Rev Clin Esp; 1984 Jun 15-30; 173(5-6):305-8. PubMed ID: 6238373
    [No Abstract]   [Full Text] [Related]  

  • 28. Gold in the dermis following gold therapy for rheumatoid arthritis.
    Cox AJ; Marich KW
    Arch Dermatol; 1973 Nov; 108(5):655-7. PubMed ID: 4201477
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunopathology of penicillamine-induced glomerular disease.
    Dische FE; Swinson DR; Hamilton EB; Parsons V
    J Rheumatol; 1976 Jun; 3(2):145-54. PubMed ID: 950631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Indentations of the glomerular basement membrane in renal diseases. A light and electron microscopic study on ultrathin serial sections.
    Tallqvist G; Pasternack A; Törnroth T
    Lab Invest; 1976 Oct; 35(4):327-36. PubMed ID: 979163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chrysotherapy-induced aplastic anemia: a case report.
    Shearer CA; Parker WA
    Am J Hosp Pharm; 1978 Sep; 35(9):1095-9. PubMed ID: 100010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Continuous chrysotherapy of rheumatoid disease (evaluation of a retrospective study of 42 cases)].
    D'eshougues JR; Delcambre B; Maquerlot M; Defrance D
    Lille Med; 1977; 22(7):430-8. PubMed ID: 412025
    [No Abstract]   [Full Text] [Related]  

  • 33. [Pathohistologic and ultrastructural features of drug-induced membranous glomerulonephritis].
    Pospishil' IuA
    Arkh Patol; 1996; 58(5):52-6. PubMed ID: 9005826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The effect of gold salts on rheumatoid factor dynamics in patients with rheumatoid arthritis].
    Vlak T; Jajić I
    Reumatizam; 1992; 39(1):11-3. PubMed ID: 1366138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The effect of Na-aurothiomalate on circulating immune complex dynamics in patients with rheumatoid arthritis].
    Vlak T; Jajić I
    Reumatizam; 1992; 39(2):1-5. PubMed ID: 1366145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gold nephropathy.
    Antonovych TT
    Ann Clin Lab Sci; 1981; 11(5):386-91. PubMed ID: 7036839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The effect of 6 months of treatment with Tauredon on clinical indicators in rheumatoid arthritis].
    Vlak T; Jajić I
    Reumatizam; 1992; 39(1):27-31. PubMed ID: 1366142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Can gold therapy be used more safely in rheumatoid arthritis? Adverse drug reactions are more likely in patients with nodular disease, independent of HLA-DR3 status.
    Shah P; Griffith SM; Shadforth MF; Fisher J; Dawes PT; Poulton KV; Thomson W; Ollier WE; Mattey DL
    J Rheumatol; 2004 Oct; 31(10):1903-5. PubMed ID: 15468351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gold nephropathy.
    Davies DJ; Dowling J; Xipell JM
    Pathology; 1977 Oct; 9(4):281-8. PubMed ID: 201907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gold-induced immune complex nephritis in seronegative rheumatoid arthritis.
    Skrifvars BV; Törnroth TS; Tallqvist GN
    Ann Rheum Dis; 1977 Dec; 36(6):549-56. PubMed ID: 145832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.